The “Art of Collaborations”: Understanding the Anatomy of Transformative Transactions in Biopharma
This article highlights the factors that drive successful collaborations and partnerships that underlie accessing transformative technologies, and financially sharing of value created through eventual successful commercialization and incorporation into the Pharma 3.0 and then Pharma 4.0 business models. We highlight the “softer factors” of the partnerships and collaborations that relate to the commonality of culture and vision of the partners and how they “fit” into a working, collaborative partnership and/or M&A transaction, and then into the ultimate product(s) and services that are brought to the market to create shared value. We posit that such transactions often fail because of reasons that do not involve either technology or market; but relate to “softer” human-related factors. For illustrative purposes, we frame our discussions around several and very successful larger top tier biopharma companies that are well known for accessing external technologies as a source for transformative innovation.
Unless specified by prior arrangement, the author agrees to the following terms and assurances:
- For myself and on behalf of the other authors listed on this work, I assign to thinkBiotech LLC the copyright* in the contribution for the full term throughout the world.
- I/we further give to the following assurances
- I am the sole author of the contribution, or, if not, I have the written authority of the other authors to transfer the copyright* to thinkBiotech LLC and give these warranties;
- I and (where appropriate) the other authors are entitled to transfer the copyright to thinkBiotech LLC and no one else would be entitled to prevent us from publishing the contribution;
- To the best of my/our knowledge, all the facts in the contribution are true and accurate;
- The content of the contribution is entirely original to me (and where appropriate to the other authors) or, if not, the written permission of the owner of the copyright in any material copied from elsewhere has been obtained for all media (all such permissions to be attached to the contribution as supplementary files);
- Nothing in the contribution is obscene or libellous;
- Nothing in the contribution infringes any duty of confidentiality which I/or the other authors may owe to anyone else.
- I and/or the other authors have obtained the appropriate clearances from my/our employer(s) or other concerned institution(s).